MWE Correspondent
Tanzania is preparing to enter a new chapter in its public health journey as the government moves forward with plans to manufacture antiretroviral medicines locally, a step expected to greatly improve access to treatment while reducing the high cost of importing essential drugs.
Officials confirmed that a pharmaceutical facility in Arusha is now fully operational and will begin producing medication for people living with HIV by June. Once production starts, the country will rely less on foreign suppliers, helping to stabilise availability and ensure that patients receive uninterrupted treatment.
Antiretroviral drugs, commonly referred to as ARVs, are vital in controlling the virus that causes HIV, allowing those infected to live longer and healthier lives. Until now, Tanzania has largely depended on imported medication, a system that has often faced challenges such as shipping delays, rising global prices and occasional shortages.
Health authorities say producing the drugs locally will not only lower costs but also strengthen the national healthcare system. Savings made from reduced imports are expected to be redirected into improving medical services, expanding treatment programmes and supporting prevention efforts.
The announcement was made during a health preparedness meeting in Arusha ahead of the 2027 Africa Cup of Nations, where officials discussed broader strategies to strengthen healthcare infrastructure in line with major international events. Leaders stressed that reliable access to essential medicines remains a national priority beyond sporting preparations.
Public health specialists have welcomed the move, describing it as a major boost in the fight against HIV/AIDS. Consistent treatment, they note, helps suppress the virus in patients’ bodies, reduces the risk of transmission and prevents the development of drug-resistant strains.
Also Read; South Africa Plans Temporary Exit From G20 During Presidency
The new manufacturing plant has been designed to meet international quality standards, with strict safety controls and trained pharmaceutical professionals overseeing production. Authorities say this will ensure locally produced medicines match the effectiveness of those previously imported.
Beyond healthcare benefits, the project is expected to contribute to economic growth. The factory will create employment opportunities and support Tanzania’s broader push to develop local industries and reduce reliance on foreign products.
Community organisations working with people affected by HIV have expressed optimism, saying stable local production could ease long-standing fears over medication shortages. Many patients depend on daily doses to stay healthy, making reliable supply a matter of life and stability.
Government officials have reaffirmed that treatment will remain affordable and accessible, especially for vulnerable groups. They also hinted that once domestic needs are fully met, Tanzania could explore supplying neighbouring countries, positioning itself as a regional centre for essential medicine production.
The shift toward local pharmaceutical manufacturing reflects a growing trend across Africa, where governments are investing in domestic production to strengthen health security and reduce dependence on international supply chains.
